BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

179 related articles for article (PubMed ID: 6184569)

  • 21. Calcium-channel blocking agents.
    Leonard RG; Talbert RL
    Clin Pharm; 1982; 1(1):17-33. PubMed ID: 6764159
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Comparative effects of felodipine ER, amlodipine and nifedipine GITS on 24 h blood pressure control and trough to peak ratios in mild to moderate ambulatory hypertension: a forced titration study.
    Lefebvre J; Poirier L; Archambault F; Jewell D; Reed CV; Lacourcière Y
    Can J Cardiol; 1998 May; 14(5):682-8. PubMed ID: 9627524
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Effects of oral calcium-antagonists in spontaneous angina. Verapamil and nifedipine in a double-blind cross-over trial.
    Piccolo E; Cazzin R; Sartori F; Artusi L; Pascotto P
    G Ital Cardiol; 1982; 12(5):359-64. PubMed ID: 6759285
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Efficacy and tolerability of extended-release felodipine and extended-release nifedipine in patients with mild-to-moderate essential hypertension.
    Fagan TC; Haggert BE; Liss C
    Clin Ther; 1994; 16(4):634-46. PubMed ID: 7982251
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Update on calcium-channel blocking agents.
    Talbert RL; Bussey HI
    Clin Pharm; 1983; 2(5):403-16. PubMed ID: 6354566
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Hypotensive action of calcium antagonists as related to plasma noradrenaline and reactivity to noradrenaline.
    Schwietzer G; Distler A; Reeck S; Thiede HM; Philipp T
    J Hypertens Suppl; 1983 Dec; 1(2):102-4. PubMed ID: 6400109
    [TBL] [Abstract][Full Text] [Related]  

  • 27. [Calcium antagonists in the treatment of arterial hypertension].
    Raczka A
    Pol Tyg Lek; 1983 Jan; 38(3):95-7. PubMed ID: 6866828
    [No Abstract]   [Full Text] [Related]  

  • 28. Metabolic effects of anti-hypertensive treatment with nifedipine or furosemide: a double-blind, cross-over study.
    Lind L; Berne C; Pollare T; Lithell H
    J Hum Hypertens; 1995 Feb; 9(2):137-41. PubMed ID: 7752176
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Efficacy of sublingual verapamil in patients with severe essential hypertension: comparison with sublingual nifedipine.
    Al-Waili NS; Hasan NA
    Eur J Med Res; 1999 May; 4(5):193-8. PubMed ID: 10336409
    [TBL] [Abstract][Full Text] [Related]  

  • 30. A new sustained-release formulation of verapamil in the treatment of hypertension.
    Midtbo KA; Hals O; Lauve O
    J Clin Hypertens; 1986 Sep; 2(3 Suppl):125S-132S. PubMed ID: 3540222
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Nilvadipine in hypertension--experience in ambulatory treatment.
    Hoffmann A; Kraul H; Burkardt I
    Int J Clin Pharmacol Ther; 1997 May; 35(5):195-203. PubMed ID: 9174874
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Antihypertensive effect of amlodipine compared with nifedipine retard in patients with mild and moderate essential hypertension.
    Kalina Z; Okopień B; Madej A; Tokarz D; Maślankiewicz A; Szwed Z; Gross-Furek V; Herman ZS
    Boll Chim Farm; 1998; 137(7):281-5. PubMed ID: 9795483
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Verapamil versus nifedipine in slow-release preparations for the treatment of mild to moderate hypertension.
    Shamiss A; Meisel S; Nussinovitch N; Rosenthal T
    J Hum Hypertens; 1990 Aug; 4(4):465-8. PubMed ID: 2258895
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Two multicenter, 8-week, randomized, double-blind, placebo-controlled, parallel-group studies evaluating the efficacy and tolerability of amlodipine and valsartan in combination and as monotherapy in adult patients with mild to moderate essential hypertension.
    Philipp T; Smith TR; Glazer R; Wernsing M; Yen J; Jin J; Schneider H; Pospiech R
    Clin Ther; 2007 Apr; 29(4):563-80. PubMed ID: 17617280
    [TBL] [Abstract][Full Text] [Related]  

  • 35. [Comparative antihypertensive action of 20 mg delayed-action nifedipine with either 25 or 50 mg atenolol. A study on the treatment of patients with mild to moderately severe arterial hypertension].
    Kraft K; Schiessl S; Vetter H
    Praxis (Bern 1994); 1996 Sep; 85(36):1081-6. PubMed ID: 8927880
    [TBL] [Abstract][Full Text] [Related]  

  • 36. [Calcium antagonists in the treatment of arterial hypertension].
    Chlewicka I; Wasowska T
    Pol Tyg Lek; 1982 Nov; 37(44):1327-9. PubMed ID: 6761674
    [No Abstract]   [Full Text] [Related]  

  • 37. Nifedipine in severely hypertensive patients with congestive heart failure and preserved ventricular systolic function.
    Given BD; Lee TH; Stone PH; Dzau VJ
    Arch Intern Med; 1985 Feb; 145(2):281-5. PubMed ID: 3156567
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Efficacy and safety of two different formulations of nifedipine (GITS) vs. slow release microgranules in patients with mild and moderate hypertension.
    Botero R; Aroca G; Asa G; González M
    J Hum Hypertens; 2002 Mar; 16 Suppl 1():S156-60. PubMed ID: 11986916
    [TBL] [Abstract][Full Text] [Related]  

  • 39. [Calcium antagonists in the treatment of chronic arterial hypertension and hypertensive crisis].
    Brandt D
    Wien Med Wochenschr; 1983 Mar; 133(6):131-5. PubMed ID: 6134398
    [TBL] [Abstract][Full Text] [Related]  

  • 40. [Sustained release verapamil in essential hypertension].
    Yodfat Y; Nusbaum M; Gibor Y
    Harefuah; 1991 May; 120(10):581-4. PubMed ID: 1937192
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.